5~10%
The win here is that the developer accesses fixed rate long-term capital and maintains flexibility to call the bonds and refinance at a lower cost

(2015) described the development of angiotensin IV analogs including Dihexa and their HGF/c-Met potentiation mechanism (PMID: 25455861) Expression of Concern: The landmark 2012 paper describing Dihexa's cognitive effects received an expression of concern from the journal (PMID: 34551989), citing data integrity issues including questioned Western blot images Retraction: A follow-up paper from the same research group was retracted (PMID: 40312093), further undermining the evidence base for Dihexa's reported effects No Human Studies: No clinical trials, pharmacokinetic studies, or safety assessments have been conducted in humans Limited Independent Replication: The core claims about Dihexa's cognitive-enhancing effects have not been independently replicated by groups outside the original laboratory The Evidence Gap: This comparison starkly illustrates the difference between a compound with decades of clinical validation (Cerebrolysin) and one with provocative preclinical data undermined by integrity concerns (Dihexa)

Drugs of epic proportion Begin at the beginning," commands the King to the White Rabbit in Carrolls Alice in Wonderland
Test results: Results for each quality test performed, including: Potency (target, acceptable range, actual result) Sterility (pass/fail) Endotoxin level (limit, actual result) pH (acceptable range, actual result) Appearance/visual inspection (clear, colorless, free of particulates) Particulate matter (pass/fail per USP 788) Specifications: The acceptable range for each test
If nothing happens, walk away and try again after breakfast